Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma – The early Australian experience
Author:
Francis Proulx-Rocray,Rebecca Symons,Yang Wang,Samrin Liaqat,Lydia Warburton,Claresta Jiang,Terence Wong,Edward Hsiao,Sydney Ch'ng,Kerwin F. Shannon,Michael Rtshiladze,Thomas E. Pennington,David J. Coker,Matteo S. Carlino,Andrew Spillane et al.
Publication:
European Journal of Cancer
© 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.